Extended Research Article
Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation
Steve J Edwards
,
Victoria Wakefield
,
Peter Cain
,
Charlotta Karner
,
Kayleigh Kew
,
Mariana Bacelar
et al.
-
Journal:
Health Technology Assessment Volume: 22, Issue: 6
-
Published:
2 February 2018